<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0190">
 <label>38</label>
 <element-citation publication-type="journal" id="h0190">
  <person-group person-group-type="author">
   <name>
    <surname>Zipursky</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Farrell</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gonzalez</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Kachra</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Folly</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Lessons learned from managing the planning and implementation of inactivated polio vaccine introduction in support of the polio endgame</article-title>
  <source>J Infect Dis</source>
  <volume>216</volume>
  <year>2017</year>
  <fpage>S15</fpage>
  <lpage>S23</lpage>
  <pub-id pub-id-type="pmid">28838203</pub-id>
 </element-citation>
</ref>
